Prothena Corp. Plc (PRTA)
9.59
+0.24
(+2.57%)
USD |
NASDAQ |
Sep 01, 16:00
9.59
0.00 (0.00%)
After-Hours: 20:00
Prothena Cash from Operations (TTM) : -61.42M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -61.42M |
| March 31, 2026 | -86.46M |
| December 31, 2025 | -168.70M |
| September 30, 2025 | -191.32M |
| June 30, 2025 | -194.54M |
| March 31, 2025 | -128.25M |
| December 31, 2024 | -147.93M |
| September 30, 2024 | -153.12M |
| June 30, 2024 | -97.02M |
| March 31, 2024 | -158.79M |
| December 31, 2023 | -133.20M |
| September 30, 2023 | -91.20M |
| June 30, 2023 | -127.85M |
| March 31, 2023 | -115.66M |
| December 31, 2022 | -105.62M |
| September 30, 2022 | -121.50M |
| June 30, 2022 | 15.78M |
| March 31, 2022 | 85.80M |
| December 31, 2021 | 89.55M |
| September 30, 2021 | 92.98M |
| June 30, 2021 | -39.23M |
| March 31, 2021 | -94.54M |
| December 31, 2020 | -84.04M |
| September 30, 2020 | -78.16M |
| June 30, 2020 | -64.87M |
| Date | Value |
|---|---|
| March 31, 2020 | -58.13M |
| December 31, 2019 | -52.40M |
| September 30, 2019 | -58.54M |
| June 30, 2019 | -82.88M |
| March 31, 2019 | -13.20M |
| December 31, 2018 | -27.35M |
| September 30, 2018 | -46.47M |
| June 30, 2018 | -35.63M |
| March 31, 2018 | -130.67M |
| December 31, 2017 | -136.93M |
| September 30, 2017 | -128.06M |
| June 30, 2017 | -136.09M |
| March 31, 2017 | -126.93M |
| December 31, 2016 | -114.24M |
| September 30, 2016 | -102.88M |
| June 30, 2016 | -89.30M |
| March 31, 2016 | -72.08M |
| December 31, 2015 | -61.64M |
| September 30, 2015 | -54.47M |
| June 30, 2015 | -50.41M |
| March 31, 2015 | -33.26M |
| December 31, 2014 | -0.6432M |
| September 30, 2014 | 1.052M |
| June 30, 2014 | 3.096M |
| March 31, 2014 | -9.914M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Alkermes Plc | 251.18M |
| Amarin Corp. Plc | 15.55M |
| Agenus, Inc. | -98.50M |
| Amgen, Inc. | 12.48B |
| Anika Therapeutics, Inc. | 5.977M |